For research use only. Not for therapeutic Use.
Triamterene is a potassium-sparing diuretic used in combination with thiazide diuretics for the treatment of hypertension and edema. Triamterene directly blocks the epithelial sodium channel (ENaC) on the lumen side of the kidney collecting tubule. Other diuretics cause a decrease in the sodium concentration of the forming urine due to the entry of sodium into the cell via the ENaC, and the concomitant exit of potassium from the principal cell into the forming urine. Blocking ENaC prevents this from happening. Amiloride works in the same way. Sodium channel blockers directly inhibit the entry of sodium into the sodium channels.
CAS Number | 396-01-0 |
Synonyms | 396-01-0; 6-phenylpteridine-2,4,7-triamine; 2,4,7-Triamino-6-phenylpteridine; Dyrenium; Triamteren |
Molecular Formula | C12H11N7 |
Purity | ≥95% |
Target | GPCR/G Protein |
Solubility | >7.9mg/mL in DMSO |
Storage | -20°C |
InChI | 1S/C12H11N7/c13-9-7(6-4-2-1-3-5-6)16-8-10(14)18-12(15)19-11(8)17-9/h1-5H,(H6,13,14,15,17,18,19) |
InChIKey | FNYLWPVRPXGIIP-UHFFFAOYSA-N |
SMILES | C1=CC=C(C=C1)C2=NC3=C(N=C2N)N=C(N=C3N)N |
Reference | 1: Hughes DS, Delori A, Rehman A, Jones W. Using crystallography, topology and <br> <br> 4: Li Y, Cheng KC, Niu CS, Lo SH, Cheng JT, Niu HS. Investigation of triamterene <br> 6: Abd El-Hay SS, Hashem H, Gouda AA. High performance liquid chromatography for 7: Shafaroodi H, Barati S, Ghasemi M, Almasirad A, Moezi L. A role for <br> 9: Ahmad Panahi H, Ejlali M, Chabouk M. Two-phase and three-phase liquid-phase 10: Smetana GW. Triamterene in the Treatment of Hypertension: More Than Just |